Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.43B | 15.24B | 20.36B | 21.52B | 22.42B |
Gross Profit | 14.43B | 15.11B | 20.36B | 21.52B | 22.42B |
EBITDA | 2.13B | 1.80B | 1.93B | 1.93B | 1.60B |
Net Income | 1.21B | 1.08B | 1.18B | 1.25B | 1.05B |
Balance Sheet | |||||
Total Assets | 218.93B | 213.44B | 217.33B | 240.65B | 237.78B |
Cash, Cash Equivalents and Short-Term Investments | 59.45B | 5.89B | 6.91B | 7.21B | 7.87B |
Total Debt | 9.41B | 9.49B | 14.83B | 13.02B | 12.86B |
Total Liabilities | 211.26B | 205.15B | 207.72B | 224.80B | 220.94B |
Stockholders Equity | 7.52B | 7.50B | 9.49B | 15.73B | 16.75B |
Cash Flow | |||||
Free Cash Flow | 56.00M | -1.08B | 918.00M | 200.00M | 421.00M |
Operating Cash Flow | 186.00M | -975.00M | 1.00B | 289.00M | 464.00M |
Investing Cash Flow | -465.00M | -111.00M | 3.00M | -194.00M | -40.00M |
Financing Cash Flow | -580.00M | -1.42B | -1.12B | -625.00M | -719.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $24.87B | 20.71 | 16.43% | 3.99% | 0.44% | 14.07% | |
68 Neutral | $17.84B | 12.03 | 10.32% | 3.73% | 9.70% | 0.76% | |
66 Neutral | CHF11.05B | 23.19 | 3.22% | 11.93% | 70.26% | ||
65 Neutral | CHF9.52B | 25.24 | 3.84% | -4.03% | 60.24% | ||
― | $102.55B | 17.97 | 23.97% | 4.56% | ― | ― | |
― | $49.11B | 14.31 | 17.22% | 4.07% | ― | ― | |
― | €2.01B | 13.11 | 6.06% | ― | ― | ― |
A recent Swiss Life study reveals that 80% of Swiss retirees aged 65 to 80 are satisfied with their lives, highlighting their positive outlook on leisure activities, social contacts, and health. Despite some experiencing loneliness and chronic health issues, the majority lead active lives, engaging in mental and physical activities and maintaining social networks. This satisfaction reflects positively on Swiss Life’s positioning as a provider of pension and financial solutions, emphasizing the importance of non-monetary aspects in retirement. The study underscores the active lifestyle and mobility of retirees, with many traveling within Europe and maintaining a high level of satisfaction with their mobility and leisure activities.
The most recent analyst rating on (CH:SLHN) stock is a Hold with a CHF707.00 price target. To see the full list of analyst forecasts on Swiss Life Holding AG stock, see the CH:SLHN Stock Forecast page.
Swiss Life has released its 2024 operating statement for its occupational benefits business in Switzerland, detailing the income statement, balance sheet, surplus fund, and investment portfolio. This release underscores Swiss Life’s commitment to transparency and compliance, potentially strengthening its position in the Swiss financial services market and providing stakeholders with valuable insights into its financial health.
The most recent analyst rating on (CH:SLHN) stock is a Hold with a CHF707.00 price target. To see the full list of analyst forecasts on Swiss Life Holding AG stock, see the CH:SLHN Stock Forecast page.
Swiss Life Holding AG reported a strong start to 2025, with significant growth in both its insurance and fee business. The company saw a 6% increase in premium income and a 3% rise in fee income, driven by its own and third-party products. Swiss Life Asset Managers also experienced robust net new money inflows, contributing to an increase in assets under management. The company’s strategic ‘Swiss Life 2027’ program aims to continue this positive trajectory, enhancing its market position and stakeholder value.
The most recent analyst rating on (CH:SLHN) stock is a Hold with a CHF707.00 price target. To see the full list of analyst forecasts on Swiss Life Holding AG stock, see the CH:SLHN Stock Forecast page.
Swiss Life Holding AG’s shareholders have approved all proposals from the Board of Directors at the company’s General Meeting, including a dividend distribution of CHF 35.00 per registered share. The meeting, attended by around 1270 shareholders, also confirmed Rolf Dörig as Chairman and re-elected the board members for another year. This approval reflects strong shareholder support and may enhance Swiss Life’s market positioning by reinforcing investor confidence and ensuring continuity in leadership.
The most recent analyst rating on (CH:SLHN) stock is a Hold with a CHF707.00 price target. To see the full list of analyst forecasts on Swiss Life Holding AG stock, see the CH:SLHN Stock Forecast page.